Traditional Chinese medicine decoction for treating neurasthenia

Abstract

The invention discloses a traditional Chinese medicine decoction for treating neurasthenia, and belongs to the field of traditional Chinese medicine. The traditional Chinese medicine decoction is prepared from, by weight, 10 parts to 20 parts of salvia miltiorrhiza, 15 parts to 25 parts of astragalus membranaceus, 5 parts to 15 parts of pinellia ternate, 5 parts to 15 parts of cinnamon, 10 parts to 20 parts of walnut kernels, 5 parts to 15 parts of folium mori, 20 parts to 40 parts of fried spina date seeds, 10 parts to 20 parts of albizia julibrissin leaves, 10 parts to 20 parts of wolfberry fruits, 15 parts to 25 parts of kelp, 20 parts to 40 parts of dragon bone, 10 parts to 20 parts of schisandra chinensis, 15 parts to 25 parts of moutan bark, 5 parts to 15 parts of sophora japonica leaves, 5 parts to 15 parts of perilla stems, 10 parts to 20 parts of hawthorns, 5 parts to 15 parts of radix glycyrrhizae preparata, 5 parts to 15 parts of coptis chinensis, 5 parts to 15 parts of angelica sinensis, 5 parts to 15 parts of prunella vulgaris, 10 parts to 20 parts of semen sesami nigrum, 10 parts to 20 parts of vines of multiflower knotweed and the like. The traditional Chinese medicine decoction prepared after the traditional Chinese medicinal materials are subjected to dialectical compatibility has the obvious improvement effects on mental retardation, weakness, distraction, irritability, dreaminess, festless sleeping, memory losing and the like of patients.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction, in particular to a traditional Chinese medicine decoction for treating neurasthenia. Background technique [0002] Neurasthenia is very common clinically, and it is a common disease in TCM internal medicine and neurology. At present, due to fierce social competition, accelerated pace of life, and high work pressure, more and more people suffer from neurasthenia. According to the results of the survey, the disease occurs mostly in people aged 16-40, and the majority are engaged in mental work, such as company white-collar workers, doctors, teachers, writers, etc., which have become high-risk groups of neurasthenia. [0003] Neurasthenia is a type of neurotic disorder characterized by mental and physical weakness, mental excitability, and mental fatigue, often accompanied by psychological and physiological symptoms such as emotional tension, worry, tension headache, and sleep disturbance,...

AI Technical Summary

Problems solved by technology

[0004] At present, the medicines for the treatment of neurasthenia are mainly western medicines. Although western medicines have a certain effect on insomnia, their adverse consequences, such as dependence, tolerance, side effects, withdrawal reactions after drug withdrawal, and economic costs, are not currently available. solved problem